2011
DOI: 10.1007/s00439-011-0964-2
|View full text |Cite
|
Sign up to set email alerts
|

Revisiting Mendelian disorders through exome sequencing

Abstract: Over the past several years, more focus has been placed on dissecting the genetic basis of complex diseases and traits through genome-wide association studies. In contrast, Mendelian disorders have received little attention mainly due to the lack of newer and more powerful methods to study these disorders. Linkage studies have previously been the main tool to elucidate the genetics of Mendelian disorders; however, extremely rare disorders or sporadic cases caused by de novo variants are not amendable to this s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
146
0
2

Year Published

2011
2011
2015
2015

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 201 publications
(149 citation statements)
references
References 105 publications
(137 reference statements)
1
146
0
2
Order By: Relevance
“…Thus, at present, the utilization of existing and impending knowledge on variants underlying Mendelian disorders to identify the variation underlying polygenic traits may prove a viable, efficient, and cost-effective complement to standard approaches such as GWAS. The present finding highlights the importance of continuing the efforts directed at studying monogenic diseases 50,51 at a time when focus has shifted away from them, as they can advance our understanding of multifactorial traits.…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…Thus, at present, the utilization of existing and impending knowledge on variants underlying Mendelian disorders to identify the variation underlying polygenic traits may prove a viable, efficient, and cost-effective complement to standard approaches such as GWAS. The present finding highlights the importance of continuing the efforts directed at studying monogenic diseases 50,51 at a time when focus has shifted away from them, as they can advance our understanding of multifactorial traits.…”
Section: Discussionmentioning
confidence: 72%
“…At present, the causal variants for a large number of monogenic disorders have been identified (over 3000 disorders; Online Mendelian Inheritance in Man (OMIM): http:// www.ncbi.nlm.nih.gov/omim), and recent developments in sequencing technologies have made it possible to employ exome sequencing or whole-genome sequencing, possibly in combination with homozygosity mapping, as an efficient approach to identifying novel causal variants underlying Mendelian disorders. [48][49][50] The National Human Genome Research Institute has opened Centers for Mendelian Genomics (NHGRI Genome Sequencing Program, http://www.genome.gov/), whose primary goal is the discovery of as yet unknown variation underlying Mendelian disorders. Thus, at present, the utilization of existing and impending knowledge on variants underlying Mendelian disorders to identify the variation underlying polygenic traits may prove a viable, efficient, and cost-effective complement to standard approaches such as GWAS.…”
Section: Discussionmentioning
confidence: 99%
“…However, while some fraction of obesity can be attributed to the aforementioned Mendelian defects as well as variation in genes identified in GWAS studies such as FTO, there is a reason to expect that many new genes remain to be discovered (Fawcett & Barroso 2010). The use of highthroughput genomic sequencing to look for variation in patients with extreme phenotypes, as pioneered by several authors in this volume, is likely to lead to the identification of new genes (Ku et al 2011). It will be of particular interest to learn whether these new genes also function in the neural circuit that is modulated by leptin and other metabolic signals.…”
Section: Obesity Has a Substantial Genetic Componentmentioning
confidence: 99%
“…However, next-generation sequencing technologies such as the whole-exome sequencing approach are improving as rapid, high-throughput, and costeffective approaches to fulfill medical sciences and research demands (Ng et al, 2009;Metzker, 2010;Ku et al, 2011). In our study, the pedigree is really small and it is difficult to discover a new causative gene.…”
Section: Discussionmentioning
confidence: 90%